跳转至内容
Merck

B9935

Sigma-Aldrich

BMS-345541

≥98% (HPLC), powder

别名:

N-(1,8-二甲基咪唑并[1,2-a] 喹喔啉-4-基)-1,2-乙二胺 盐酸盐

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C14H17N5 · HCl
分子量:
291.78
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

powder

儲存條件

desiccated

溶解度

DMSO: 18 mg/mL
H2O: insoluble

起源

Bristol-Myers Squibb

儲存溫度

2-8°C

SMILES 字串

Cl[H].Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1

InChI

1S/C14H17N5.ClH/c1-9-3-4-11-12(7-9)19-10(2)8-17-14(19)13(18-11)16-6-5-15;/h3-4,7-8H,5-6,15H2,1-2H3,(H,16,18);1H

InChI 密鑰

MIDKPVLYXNLFGZ-UHFFFAOYSA-N

應用

BMS-345541已用于:
  • 作为IκB 激酶 (IKK) 复合抑制剂,研究其对由自然杀伤 (NK) 细胞产生的干扰素γ (IFN-γ)的影响
  • 作为 IKK 抑制剂,研究其对牙龈成纤维细胞中嗜酸性粒细胞趋化因子和单核细胞趋化蛋白-1 (MCP-1) mRNA 表达的影响
  • 作为核因子 κB (NF-κB) 通路抑制剂,研究其对在人口腔鳞状细胞癌细胞所产生的肿瘤坏死因子α (TNFα)的影响

生化/生理作用

BMS-345541 具有抗炎特性。它还可以阻断促炎细胞因子的核因子 κB (NF-κB) 依赖性转录。BMS-345541具有抗炎活性,并在某些动物模型中起到阻止骨侵蚀的作用。
BMS-345541是一种 IKB(IKK)变构位点抑制剂。

特點和優勢

该化合物由Bristol-Myers Squibb开发。要浏览其他药物开发化合物和批准的药物/候选药物列表,请点击此处
这种化合物是基因调控研究的特色产品。点击此处发现更多特色基因调控产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

James R Burke et al.
The Journal of biological chemistry, 278(3), 1450-1456 (2002-10-31)
The signal-inducible phosphorylation of serines 32 and 36 of I kappa B alpha is critical in regulating the subsequent ubiquitination and proteolysis of I kappa B alpha, which then releases NF-kappa B to promote gene transcription. The multisubunit I kappa
Neety Sahu et al.
JCI insight, 7(20) (2022-10-05)
No disease-modifying drug exists for osteoarthritis (OA). Despite success in animal models, candidate drugs continue to fail in clinical trials owing to the unmapped interpatient heterogeneity and disease complexity. We used a single-cell platform based on cytometry by time-of-flight (cyTOF)
Christina Ward et al.
Tissue barriers, 3(1-2), e982424-e982424 (2015-04-04)
NF-κB (p50/p65) is the best characterized transcription factor known to regulate cell responses to inflammation. However, NF-κB is also constitutively expressed. We used inhibitors of the classical NF-κB signaling pathway to determine whether this transcription factor has a role in
Qinghai You et al.
Inflammation research : official journal of the European Histamine Research Society ... [et al.], 69(1), 75-85 (2019-11-07)
Acute respiratory distress syndrome (ARDS) is a life-threatening medical condition. It is characterized by serious lung inflammation or injury. Characterizing novel miRNAs implicated in ARDS pathogenesis may provide new therapeutic strategy for managing ARDS. We employed LPS-induced lung injury model
Feng He et al.
The Journal of experimental medicine, 218(3) (2020-12-15)
White adipose tissues (WAT) play crucial roles in maintaining whole-body energy homeostasis, and their dysfunction can contribute to hepatic insulin resistance and type 2 diabetes mellitus (T2DM). However, the mechanisms underlying these alterations remain unknown. By analyzing the transcriptome landscape

商品

We offer a variety of small molecule research tools, such as transcription factor modulators, inhibitors of chromatin modifying enzymes, and agonists/antagonists for target identification and validation in gene regulation research; a selection of these research tools is shown below.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门